Global Dementia Drugs Market, By Drug Class (Cholinesterase Inhibitors, MAO Inhibitors, and Glutamate Inhibitors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2029

Dementia is a disease related to the brain, which include various symptoms such as memory loss, difficulties with problem solving, thinking and language. Furthermore dementia is characterized with group of symptoms associated with a decline in memory and difficulties with thinking, problem-solving or language; severe enough to reduce person’s ability to perform daily activities. Alzheimer\'s disease is the most common and known type of dementia, in adults, accounts for 60% to 80% of overall dementia cases. Various other type of dementia includes Huntington’s disease, Frontotemporal dementia, Creutzfeldt- Jakob disease, Down’s syndrome, Dementia with Lewy Bodies, mixed dementia, Parkinson’s disease dementia, vascular dementia, among others.  

Growing incidence rate of Alzheimer’s disease among the global population, larger number of pipeline drugs in the treatment of dementia, along with substantial engagement of various key players in gaining regulatory product approval, will eventually drive the dementia drug market, in near future. For instance, in August 2017, Zydus Cadila has received U.S. Food and Drug Administration (FDA) approval to market Memantine Hydrochloride extended-release capsules (7 mg, 14 mg, 21 mg and 28 mg strengths) in the treatment of moderate to severe dementia of Alzheimer’s type.  

The global dementia drugs market has been segmented on the basis of drug class, distribution channel and region.

The drug class segment includes cholinesterase inhibitors, mao inhibitors, and glutamate inhibitors. Further the dementia drug market is segmented by distribution channel, which include hospital pharmacy, retail pharmacy and other distribution channel.

On the basis of region, the above market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is expected to hold major market share in the dementia drugs market, during the fiscal year 2018, owing to the higher number of dementia drug approvals in these region and availability of favorable reimbursement policies. Moreover, Asia Pacific region accounts to hold higher CAGR during the forecast period, due to the increasing presence of Alzheimer’s cases, combined with subsequent growing geriatric population, especially in the India and China.   

The key players operating in the global dementia drug market include Eli Lilly and Company, Cadila Healthcare Ltd., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Eisai Co., Ltd., Novartis AG, Forest Laboratories, Inc., and F. Hoffmann-La Roche.

Research Objective and Assumption

• Preface
• Research Objectives
• Study Scope
• Years Considered for the study
• Assumptions
• Abbreviations

Research Methodology

• Research data
• Primary Data
  • Primary Interviews
  • Primary Breakdown
  • Key data from Primary Sources
  • Key Thickness Insights
• Secondary Data
  • Major Secondary Sources
  • Secondary Sources
• Market Estimation
• Top-Down Approach
  • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
• Bottom-Up Approach
  • Approach for estimating market share by Bottom-up Analysis (Demand Side)
• Market Breakdown and Data Triangulation
• Research Assumptions

Market Preview

• Executive Summary
• Key Findings—Global Outlook for medical carts Strategies
  • Key Questions this Study will Answer
  • Market Snippet, By Drug Class
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Opportunity Map Analysis
• Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restrains
  • Market Opportunities
  • Market Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis

Dementia Drugs Market, By Drug Class, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Cholinesterase Inhibitors
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• MAO Inhibitors
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Glutamate Inhibitors
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Dementia Drugs Market, By Distribution Channel, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospital Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Retail Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Dementia Drugs Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America

 

• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Drug Class, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles

•  Eli Lilly and Company
  •   Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cadila Healthcare Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Janssen Pharmaceuticals, Inc.
  •  Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eisai Co., Ltd.
  •  Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Novartis AG
  •  Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Forest Laboratories, Inc.,
  •  Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• F. Hoffmann-La Roche.
  •  Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact